Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells

Clinical and Experimental Metastasis

Volumn 14, Issue 3, 1996, Pages 239-245

  Moore, Theodore B ^a   Koeffler, H Phillip ^a   Yamashiro, Joyce M ^a   Wada, Randal K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Differentiation; Invasion; N myc; Neuroblastoma; Vitamin D3 analogs

Indexed keywords

ACETYLCHOLINESTERASE; LEXACALCITOL; SEOCALCITOL; ANTINEOPLASTIC AGENT; CALCITRIOL; COLECALCIFEROL; DRUG DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NEUROBLASTOMA; ONCOGENE C MYB; CANCER INVASION; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; GENETICS; METABOLISM; ONCOGENE MYC; PATHOLOGY; STAINING;

ACETYLCHOLINESTERASE; ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CHOLECALCIFEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; NEOPLASM INVASIVENESS; NEUROBLASTOMA; STAINING AND LABELING; TUMOR CELLS, CULTURED;

EID: 0029665198     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Young JLJ, Ries LG, Silverberg E et al, 1986, Cancer incidence, survival and mortality for children younger than 15 years. Cancer, 58, 598.
2. Abemayor E and Sidell N, 1989, Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Envir Hlth Perspect, 80, 3-15.
3. Evans AE, Chatten J, D'Angio GJ et al, 1980, A review of 17 IV-S neuroblastoma patients at the Children's Hospital of Philadelphia. Cancer, 45, 833-9.
4. Lando M, Abemayor E, Verity MA et al, 1990, Modulation of intracellular cyclic adenosine monophosphate levels and the differentiation response of human neuroblastoma cells. Cancer Res, 50, 722-7.
5. Wuarin L, Verity MA and Sidell N, 1991, Effects of interferon-gamma and its interactions with retinoic acid on human neuroblastoma differentiation. Int J Cancer, 48, 136-41.
6. 3) on LA-N-5 human neuroblastoma cells, and its synergy with retinoic acid. Am J Ped Hem Oncol, in press.
7. Sidell N, Wada R, Han G et al, 1995, Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells. Int J Cancer, 60, 507-14.
8. Sidell N, Lucas CA and Kreutzberg GW, 1984, Regulation of acetyl-cholinesterase activity by retinoic acid in a human neuroblastoma cell line. Expl Cell Res, 155, 305-9.
9. 3 induced differentiation in human promyelocytic leukemia cell line (HL-60): receptor mediated maturation to macrophage-like cells. J Cell Biol, 98, 391.
10. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep, 69, 1399.
11. Ikegaki N, Bukovsky J and Kennet RH, 1986, Identification and characterization of the N-myc gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc Natl Acad Sci, 83, 5929-33.
12. Thiele C and Israel MA, 1988, Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. Expl Cell Biol, 56, 321-33.
13. Thiele CT, Reynolds CP and Israel MA, 1985, Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature, 313, 404-6.
14. Seeger RC, Brodeur GM, Sather H et al, 1985, Association of multiple copies of the N-myc oncogene with rapid progession of neuroblastoma. N Engl J Med, 313, 111-16.
15. Bernards R, Dessain SK and Weinberg RA, 1986, N-myc amplification causes down modulation of MHC Class I antigen expression in neuroblastoma. Cell, 47, 667-74.
16. Tabin CJ, 1991, Retinoids, homeoboxes, and growth factors: toward molecular models for limb development. Cell, 66, 199-217.
17. 3 and its fluorinated analogues. Cancer Res, 44, 5624.
18. 3, retinoic acid and dexamethasone. Anti-cancer Drugs, 4, 201-8.
19. 3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line. Cancer Invest, 13, 280-6.
20. 3 in a keratinocyte model of tumor progression. J Biol Chem, 267, 12162-7.
21. 3. Endocrinology, 136, 20-6.
22. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmac, 42, 1569-75.
23. 3 analogs. Leukemia Res, 19, 65-72.
24. 3 prolongs survival time of leukemic mice. Proc Natl Acad Sci, 87, 3929-32.
25. Colston KW, Mackay AG, James SY et al, 1992, EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmac, 44, 2273-80.